| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.234 | 3.192 | 5.822 | 9.612 | 7.605 | 16.634 |
| Total Income - EUR | - | - | - | - | 8.234 | 3.192 | 5.822 | 9.612 | 8.092 | 17.415 |
| Total Expenses - EUR | - | - | - | - | 2.865 | 1.516 | 2.334 | 2.653 | 7.723 | 10.213 |
| Gross Profit/Loss - EUR | - | - | - | - | 5.369 | 1.676 | 3.488 | 6.958 | 369 | 7.202 |
| Net Profit/Loss - EUR | - | - | - | - | 5.122 | 1.581 | 3.313 | 6.670 | 18 | 5.417 |
| Employees | - | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medrux-Sana S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 680 | 409 | 147 | 1.378 | 28.623 | 23.340 |
| Current Assets | - | - | - | - | 6.130 | 8.695 | 4.451 | 5.480 | 729 | 6.168 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 877 | 0 | 776 | 844 | 0 | 2.808 |
| Cash | - | - | - | - | 5.253 | 8.695 | 3.674 | 4.637 | 729 | 3.360 |
| Shareholders Funds | - | - | - | - | 5.164 | 1.622 | 3.353 | 6.711 | 6.664 | 12.045 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.646 | 7.482 | 1.245 | 147 | 19.839 | 15.411 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 2.849 | 2.052 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medrux-Sana S.r.l.